December 13, 2016
Eli Lilly cuts insulin prices
Eli Lilly has announced that people who use Lilly insulin will be able to access discounted prices for their purchases…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
December 13, 2016
GSK substitutes Pricewaterhouse with Delloite
GSK has announced on Tuesday that it intends to appoint Deloitte LLP (“Deloitte”) as its auditor with effect from the…
December 13, 2016
OptiBiotix’s SlimBiome technology for food and OTC products in Asian market
OptiBiotix Health has entered into a joint development agreement with a multinational for the development of food and Over The Counter…
December 13, 2016
4D pharma’s Blautix for Irritable Bowel Syndrome shows positive impact
4D Pharma’s Blautix, a single strain live biotherapeutic for the treatment of chronic abdomen disorder, Irritable Bowel Syndrome (IBS), has…
December 13, 2016
Eli Lilly announces dividend increase
The board of directors of Eli Lilly has announced a 2 percent increase in its quarterly dividend. The dividend for…
December 13, 2016
Short: Active Biotech’s rights issue completed
Active Biotech has announced on Tuesday that following the end of the subscription period, the results of Active Biotech’s rights issue…
December 13, 2016
Zealand Pharma increases share capital
Zealand Pharma has on Monday increased its share capital with nominal DKK 13,999 divided into 13,999 new shares with a…
December 13, 2016
Type 2 diabetes gets new treatment in U.S., FDA OKs Boehringer’s Synjardy XR
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Synjardy XR tablets for adults with type 2 diabetes.…
December 12, 2016
Novartis’s Monaleesa study show PFS in breast cancer treatment
Novartis has announced additional analyses from the Phase III MONALEESA-2 study that show LEE011 (ribociclib) plus letrozole significantly prolonged progression-free…
December 12, 2016
Achaogen passes US and European hurdles to market its plazomicin antibiotic
Achaogen’s multi-drug resistant (MDR) gram-negative product antibiotic candidate, plazomicin, met the objective for the U.S. Food and Drug Administration (FDA)…